Ananda Pharma Cuts Epilepsy Plans, Focuses Capital on MRX1
Ananda Pharma, one of many UK’s main clinical-stage pharmaceutical hashish firms, has introduced a string of strategic pivots, together with […]
Ananda Pharma, one of many UK’s main clinical-stage pharmaceutical hashish firms, has introduced a string of strategic pivots, together with […]
The afternoon classes at Tuesday’s inaugural Hashish Well being Symposium 2025 moved past the basics of hashish drugs and its
A UK Crown Court docket has thrown out legal costs towards CBD hemp flower importers after ruling that police mishandled
First printed on Hashish Well being Medical hashish sufferers made historical past in London with a first-of-its-kind, patient-led training occasion
Germany’s Bundesrat voted on November 21 to assist key restrictions on medical hashish prescribing and distribution, whereas rejecting proposals to
The UK financial progress faces a paradox of two seemingly opposing pressures, but each could also be resolved by transferring
Key Information Gaps Highlighted By EFSA EFSA identifies a basic absence of managed human knowledge at related publicity ranges, stating
The sweeping redefinition of ‘hemp’ within the US following the passage of the funding invoice threatens non-intoxicating CBD processors whereas
Newlake Capital Q3 earnings are extra optimistic than they first seem NewLake Capital Companions, one of many largest cannabis-focused
Deciphering the Outcomes: Past the Headline As soon as the strategies maintain up, the subsequent step is to interpret the